Constipation is a common clinical problem with a multifactorial etiology, often causing significant discomfort and negatively impacting the quality of life. Despite its frequency, it remains underdiagnosed and undertreated in clinical practice. This article aims to provide a comprehensive approach to diagnosing and treating constipation.
Diagnosis begins with a thorough history and physical examination, focusing on diet, lifestyle, medication use, and psychosocial factors. It is crucial to differentiate between chronic functional constipation and secondary constipation. Where necessary, diagnostic tests such as anorectal manometry, colonic transit studies, and defecography can be employed to identify underlying pathophysiology.
Management strategies should be individualized, considering the patient's preferences, lifestyle, and underlying causes. Initial treatment typically involves lifestyle modifications, including increased dietary fiber, fluid intake, and physical activity. Pharmacological therapies, such as laxatives, are used as second-line treatment. For patients who do not respond to these measures, more advanced treatments such as biofeedback therapy or surgery may be considered.
Emerging evidence suggests a role for gut microbiota in the pathogenesis of constipation. Probiotics, particularly Bifidobacterium and Lactobacillus species, have shown promise in improving bowel frequency and consistency. However, more robust clinical trials are needed to confirm these findings and to establish optimal dosing and duration of therapy.
Constipation is a prevalent condition that requires a comprehensive, individualized approach to diagnosis and management. Clinicians should be vigilant in identifying secondary causes and promptly initiating appropriate treatment. Emerging therapies such as probiotics represent exciting new avenues for treatment. However, further research is needed to fully elucidate their role in managing constipation.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation